Prudential Financial
TCRT icon

Prudential Financial’s Alaunos Therapeutics TCRT Stock Holding History

Prudential Financial’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-102
Closed -$10K – 2744
2022
Q1 		$10K Hold
102
– – ﹤0.01% 2594
2021
Q4 		$17K Sell
102
-9
-8% -$1.98K ﹤0.01% 2616
2021
Q3 		$30K Buy
111
+4
+4% +$1.22K ﹤0.01% 2568
2021
Q2 		$42K Buy
107
+1
+0.9% +$467 ﹤0.01% 2524
2021
Q1 		$57K Buy
106
+6
+6% +$3.73K ﹤0.01% 2455
2020
Q4 		$38K Hold
100
– – ﹤0.01% 2416
2020
Q3 		$38K Sell
100
-2
-2% -$884 ﹤0.01% 2399
2020
Q2 		$50K Buy
102
+18
+21% +$8.03K ﹤0.01% 2360
2020
Q1 		$31K Sell
84
-10
-11% -$5.17K ﹤0.01% 2316
2019
Q4 		$67K Hold
94
– – ﹤0.01% 2387
2019
Q3 		$60K Sell
94
-17
-15% -$13.5K ﹤0.01% 2379
2019
Q2 		$97K Buy
111
+17
+18% +$11.7K ﹤0.01% 2400
2019
Q1 		$54K Hold
94
– – ﹤0.01% 2399
2018
Q4 		$26K Sell
94
-2
-2% -$791 ﹤0.01% 2352
2018
Q3 		$46K Buy
96
+2
+2% +$858 ﹤0.01% 2398
2018
Q2 		$43K Hold
94
– – ﹤0.01% 2407
2018
Q1 		$55K Buy
94
+2
+2% +$1.25K ﹤0.01% 2320
2017
Q4 		$57K Sell
92
-7
-7% -$5.03K ﹤0.01% 2311
2017
Q3 		$91K Buy
99
+2
+2% +$1.78K ﹤0.01% 2302
2017
Q2 		$91K Buy
97
+12
+14% +$11.8K ﹤0.01% 2301
2017
Q1 		$81K Hold
85
– – ﹤0.01% 2298
2016
Q4 		$68K Hold
85
– – ﹤0.01% 2310
2016
Q3 		$72K Buy
85
+5
+6% +$4.02K ﹤0.01% 2287
2016
Q2 		$66K Buy
80
+6
+8% +$6.53K ﹤0.01% 2270
2016
Q1 		$82K Sell
74
-2
-3% -$2.05K ﹤0.01% 2260
2015
Q4 		$94K Hold
76
– – ﹤0.01% 2195
2015
Q3 		$103K Hold
76
– – ﹤0.01% 2173
2015
Q2 		$136K Buy
+76
New +$118K ﹤0.01% 2171
2014
Q3 		– Sell
-98
Closed -$60K – 2301
2014
Q2 		$60K Buy
+98
New +$54.6K ﹤0.01% 2376

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Prudential Financial's TCRT Position: Q2 2022 in Review

Prudential Financial sold out of Alaunos Therapeutics (TCRT) in Q2 2022, closing a stake of 102 shares — an estimated $10K sold.

Prudential Financial first reported a position in TCRT in Q2 2014 and held it in 29 quarters. The position peaked at $136K in Q2 2015. 124 funds tracked by Wall St. Rank hold TCRT as of Q2 2022.

  • Prudential Financial reported no remaining Alaunos Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Prudential Financial sold 102 Alaunos Therapeutics shares in Q2 2022, an estimated $10K.
  • Prudential Financial first reported a position in Alaunos Therapeutics in Q2 2014 and held it in 29 quarters.
  • Prudential Financial's Alaunos Therapeutics position peaked at $136K in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q2 2022.

Based on Prudential Financial's 13F filing for Q2 2022, filed 15 Aug 2022.